Current Research Limitations Most clinical studies on GHK-Cu involve: Topical formulations In vitro research Animal models Systemic (non-injectable) delivery There is insufficient evidence in peer-reviewed literature to support: standardized injection techniques validated injectable dosing regimens long-term safety or efficacy data for injectable use As a result, clinicians should approach injectable discussions with caution and rely on evidence-based peptide education rather than anecdotal protocols
Always add water slowly with a vented needle technique if needed
Mahdian D, Abbaszadeh-Goudarzi K, Raoofi A, et al
NS optional) Vita Blend B1 300mg, B2 6mg, B3 300mg, B5 6mg, B6 6mg Amino Blend Proline 50mg, Arginine 100mg, Lysine 50mg, Citrulline 50mg Ascorbic Acid (Vitamin C) 2000mg Magnesium Chloride 600mg Zinc Sulfate 10mg Alpha Lipoic Acid (ALA) 100mg (pre-infusion push) NAD+ 200mg (secondary NS or LR 500ml bag
Most often the functional nomenclature for renal transporters can be a bit confusing as well since a common theme is to indicate a transporter present on the basolateral (blood side) membrane is functioning as secretion transporter while a transporter found in the apical (luminal side) membrane is functioning as an uptake or reabsorption transporter